About 130 million people are infected with the hepatitis C virus (HCV) worldwide, but effective treatment options are not yet available. One of the most promising targets for antiviral therapy is nonstructural protein 3 (NS3).
To identify possible changes in the structure of NS3 associated with virological sustained response or non-response of patients, a model was constructed for each helicase NS3 protein coding sequence. From this, the goal was to verify the interaction between helicases variants and their ligands.FindingsEvidence was found that the NS3 helicase portion of non-responder patients contained substitutions in its ATP and RNA binding sites.
K210E substitution can cause an imbalance in the distribution of loads, leading to a decrease in the number of ligations between the essential amino acids required for the hydrolysis of ATP. W501R substitution causes an imbalance in the distribution of loads, leading and forcing the RNA to interact with the amino acid Thr269, but not preventing binding of ribavirin inhibitor.
Conclusions: Useful information is provided on the genetic profiling of the HCV genotype 3, specifically the coding region of the NS3 protein, improving our understanding of the viral genome and the regions of its protein catalytic site.
Author: Paola ProvazziHelen ArcuriIsabel Maria de Carvalho-MelloJoao Renato PinhoMauricio NogueiraMario PalmaPaula Rahal
Credits/Source: BMC Research Notes 2010, 3:196
Published on: 2010-07-14
Source
No comments:
Post a Comment